News & Events

Our news posts are an easy way to keep up-to-date with all our latest developments. View the event posts to stay informed of all our upcoming events and activities.

Cellectricon receives EcoVadis Sustainability Rating

Cellectricon, a services provider dedicated to advancing drug discovery and research in neuroscience, has been awarded a Bronze Medal by...

Development of human in vitro models for the study of pain

In September, Cellectricon welcomed our new coworker Andrea Lovincic Babic to the team. Andrea will carry out her PhD project...

A PhD position in pain research available in collaboration with Karolinska Institutet

We are looking for a new colleague for an open position as PhD fellow in the EU-funded Marie Skłodowska-Curie Actions...

Sign up to get news & events updates from Cellectricon

Cellectricon and Fluicell initate collaboration to validate tissue-based in vitro models

We’re excited to be working with Fluicell AB and support their development of bioprinted tissues for use in research and...

Cellectricon launches Neuroinflammation Research Service

MÖLNDAL, SWEDEN Cellectricon, a services provider dedicated to advancing neuroscience drug discovery, has launched the Neuroinflammation Research Service module. Established...

Dr. Jonathan Levenson joins Cellectricon’s advisory board

Cellectricon has appointed Dr. Jonathan Levenson, Chief Scientific Officer at FireCyte Therapeutics, to its Scientific Advisory Board. Dr. Levenson brings...

Sign up to get news & events updates from Cellectricon

Cellectricon’s expertise in pain research recognized by second EU research grant

MÖLNDAL, SWEDEN Cellectricon, a services provider dedicated to advancing neuroscience drug discovery, has received follow-on funding for bone pain research...

Senior Scientist, high content imaging and analysis

Cellectricon is an innovative discovery services provider with a focus on the neurobiology of peripheral and central nervous system diseases....

New publication: A Microfluidic High-Capacity Screening Platform for Neurological Disorders

We are happy to announce the publication of “A Microfluidic High-Capacity Screening Platform for Neurological Disorders”. In the paper, published...